MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants. IHRJ [Internet]. 2026 June 1 [cited 2026 Aug. 19];3((1-Supp):05-16. Available from: https://journal.ucc.edu.gh/index.php/ihrj/article/view/2075